NDC 0363-7760 Walgreens Maximum Strength Severe Congestion And Cough
Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride Liquid Oral
Product Information
What is NDC 0363-7760?
The NDC code 0363-7760 is assigned by the FDA to the product Walgreens Maximum Strength Severe Congestion And Cough which is a human over the counter drug product labeled by Walgreen Company. The generic name of Walgreens Maximum Strength Severe Congestion And Cough is dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 0363-7760-06 180 ml in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.
Product Details
What are Walgreens Maximum Strength Severe Congestion And Cough Active Ingredients?
- DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL - Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
- GUAIFENESIN 400 mg/20mL - An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
- PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL - An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.
Pharmacologic Class(es)
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.